Revvity, Inc. (RVTY)

Market Cap	13.70B
Revenue (ttm)	2.72B
Net Income (ttm)	254.30M
Shares Out	121.70M
EPS (ttm)	2.06
PE Ratio	53.79
Forward PE	22.53
Dividend	$0.28 (0.25%)
Ex-Dividend Date	Jan 17, 2025

Volume	625,745
Open	110.15
Previous Close	110.54
Day's Range	110.15 - 113.66
52-Week Range	97.32 - 129.50
Beta	1.03
Analysts	Buy
Price Target	129.80 (+15.32%)
Earnings Date	Jan 30, 2025

About RVTY

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its pro...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1937
• Employees: 11,500
• Stock Exchange: NYSE
• Ticker Symbol: RVTY
• Website: https://www.revvity.com

Financial Performance

In 2023, Revvity's revenue was $2.75 billion, a decrease of -16.95% compared to the previous year's $3.31 billion. Earnings were $693.09 million, an increase of 21.77%.

Analyst Forecast

According to 15 analysts, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $129.8, which is an increase of 15.32% from the latest price.

Price Target

$129.8

(15.32% upside)

Analyst Consensus: Buy